Home / Conditions / Hepatitis_c

Hepatitis_c: when insurers say no, reviewers often say yes

In 134 published external-review decisions involving hepatitis_c, independent physician reviewers overturned the insurer’s denial 88.1% of the time.

Published decisions
134
2001–2026
Overturned
88.1%
118 denials reversed

Most-fought treatments for hepatitis_c

What insurers denied — and how those fights ended.
TreatmentDecisionsOverturned
Harvoni66
90.9%
Mavyret21
100%
Zepatier13
76.9%
How to use this in your appeal

These outcomes come from California’s external review program — an independent physician panel whose decision binds the insurer. Every state has an equivalent, and internal appeals succeed even more often. If your care for hepatitis_c was denied, the published record says the denial is worth fighting.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for hepatitis_c? 88.1% won.

Explain my denial — free